| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Ana Mari Cauce: leader of a new initiative in population health
|
Lane, Richard
|
|
|
389 |
10075 |
p. 1185
|
artikel
|
| 2 |
ANTARCTIC: platelet function testing to adjust therapy
|
Hideo-Kajita, Alexandre
|
|
|
389 |
10075 |
p. 1192-1193
|
artikel
|
| 3 |
ANTARCTIC: platelet function testing to adjust therapy
|
Gurbel, Paul A
|
|
|
389 |
10075 |
p. 1193
|
artikel
|
| 4 |
ANTARCTIC: platelet function testing to adjust therapy – Authors' reply
|
Montalescot, Gilles
|
|
|
389 |
10075 |
p. 1193-1194
|
artikel
|
| 5 |
Chronic Kidney Disease
|
Webster, Angela C
|
|
|
389 |
10075 |
p. 1238-1252
|
artikel
|
| 6 |
Department of Error
|
|
|
|
389 |
10075 |
p. e4
|
artikel
|
| 7 |
Department of Error
|
|
|
|
389 |
10075 |
p. 1194
|
artikel
|
| 8 |
Department of Error
|
|
|
|
389 |
10075 |
p. 1194
|
artikel
|
| 9 |
Department of Error
|
|
|
|
389 |
10075 |
p. e4
|
artikel
|
| 10 |
Department of Error
|
|
|
|
389 |
10075 |
p. e4
|
artikel
|
| 11 |
Department of Error
|
|
|
|
389 |
10075 |
p. 1194
|
artikel
|
| 12 |
Efficacy and safety of sirukumab in patients with active rheumatoid arthritis refractory to anti-TNF therapy (SIRROUND-T): a randomised, double-blind, placebo-controlled, parallel-group, multinational, phase 3 study
|
Aletaha, Daniel
|
|
|
389 |
10075 |
p. 1206-1217
|
artikel
|
| 13 |
Encountering pain
|
Padfield, Deborah
|
|
|
389 |
10075 |
p. 1177-1178
|
artikel
|
| 14 |
Feedback of results to trial participants: be upfront or risk affront
|
Beamish, Andrew J
|
|
|
389 |
10075 |
p. 1191-1192
|
artikel
|
| 15 |
Getting pandemic prevention right
|
Dahn, Bernice
|
|
|
389 |
10075 |
p. 1189
|
artikel
|
| 16 |
Hypertrophic obstructive cardiomyopathy
|
Veselka, Josef
|
|
|
389 |
10075 |
p. 1253-1267
|
artikel
|
| 17 |
Images and the dynamics of pain consultations
|
Semino, Elena
|
|
|
389 |
10075 |
p. 1186-1187
|
artikel
|
| 18 |
Importation of generic hepatitis C therapies: bridging the gap between price and access in high-income countries
|
Ghinea, Narcyz
|
|
|
389 |
10075 |
p. 1268-1272
|
artikel
|
| 19 |
Interleukin-6 inhibition for rheumatoid arthritis
|
Fleischmann, Roy
|
|
|
389 |
10075 |
p. 1168-1170
|
artikel
|
| 20 |
Iraq's health system under pressure as fighting escalates
|
Zarocostas, John
|
|
|
389 |
10075 |
p. 1182
|
artikel
|
| 21 |
Is intensity the solution for FMT in ulcerative colitis?
|
Siegmund, Britta
|
|
|
389 |
10075 |
p. 1170-1172
|
artikel
|
| 22 |
Margaret Mungherera
|
Green, Andrew
|
|
|
389 |
10075 |
p. 1188
|
artikel
|
| 23 |
Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial
|
Paramsothy, Sudarshan
|
|
|
389 |
10075 |
p. 1218-1228
|
artikel
|
| 24 |
New plan to end tuberculosis in south and southeast Asia
|
Sharma, Dinesh C
|
|
|
389 |
10075 |
p. 1183
|
artikel
|
| 25 |
Offline: The dark heart of the wood
|
Horton, Richard
|
|
|
389 |
10075 |
p. 1179
|
artikel
|
| 26 |
Optimal duration of trastuzumab for early HER2-positive breast cancer
|
Specht, Jennifer M
|
|
|
389 |
10075 |
p. 1167-1168
|
artikel
|
| 27 |
Preparing for future global health emergencies
|
The Lancet,
|
|
|
389 |
10075 |
p. 1166
|
artikel
|
| 28 |
Reducing global tuberculosis deaths—time for India to step up
|
Pai, Madhukar
|
|
|
389 |
10075 |
p. 1174-1176
|
artikel
|
| 29 |
Social rank: a risk factor whose time has come?
|
Tobias, Martin
|
|
|
389 |
10075 |
p. 1172-1174
|
artikel
|
| 30 |
Socioeconomic status and the 25 × 25 risk factors as determinants of premature mortality: a multicohort study and meta-analysis of 1·7 million men and women
|
Stringhini, Silvia
|
|
|
389 |
10075 |
p. 1229-1237
|
artikel
|
| 31 |
Sustaining tuberculosis decline in the UK
|
Adam, Bilaal U
|
|
|
389 |
10075 |
p. 1176-1177
|
artikel
|
| 32 |
The need to revise the Helsinki Declaration
|
Asplund, Kjell
|
|
|
389 |
10075 |
p. 1190-1191
|
artikel
|
| 33 |
The revised US refugee ban, health, and security
|
Rubenstein, Leonard
|
|
|
389 |
10075 |
p. 1189-1190
|
artikel
|
| 34 |
Tracheal implants revisited
|
Frostell, Claes
|
|
|
389 |
10075 |
p. 1191
|
artikel
|
| 35 |
Trauma for migrant children stranded in Greece
|
The Lancet,
|
|
|
389 |
10075 |
p. 1166
|
artikel
|
| 36 |
Triumph over adversity
|
Glyde, Tania
|
|
|
389 |
10075 |
p. 1184
|
artikel
|
| 37 |
US health and science advocates gear up for battle over EPA
|
Jaffe, Susan
|
|
|
389 |
10075 |
p. 1180-1181
|
artikel
|
| 38 |
What has Europe ever done for health?
|
The Lancet,
|
|
|
389 |
10075 |
p. 1165
|
artikel
|
| 39 |
11 years' follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trial
|
Cameron, David
|
|
|
389 |
10075 |
p. 1195-1205
|
artikel
|
Tijdschrift beschrijving